longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Surrozen

SRZN

29.3202.27% ( -0.680 )
Closed: Oct 2, 16:00:00 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • Surrozen Initiated with Buy as IND Clearance, New Capital and External Wnt Validation Strengthen Clinical Momentum

    Tip Ranks·1 day ago, 02:15 PM
    SRZN-2.27%
  • Surrozen says FDA clears IND for SZN-8141 diabetic macular edema trial

    PUBT·1 day ago, 12:00 PM
    SRZN-2.27%
  • Litigation, Battery Launches and Biotech Research Drive Small-Cap Week

    Global Report·Sep 30 at 10:14 AM
    GPAK0.00%AIQD-1.38%
  • Weekly Recap | Surrozen +78.49%, closing in on record highs

    Weekly Review·Sep 26 at 07:07 AM
    SRZN-2.27%
  • Surrozen jumps 99% on FDA clinical trial filing for SZN-8141 eye therapy

    US Stock Market Update·Sep 24 at 06:57 PM
    SRZN-2.27%
  • 12 Health Care Stocks Moving In Thursday's Intraday Session

    benzinga_article·Sep 24 at 05:06 PM
    ARTL-3.92%SRZN-2.27%
  • Crude Oil Rises Over 4%; Darden Earnings Miss Views

    benzinga_article·Sep 24 at 04:02 PM
    - U.S. stocks traded lower on Thursday as the Dow Jones fell 0.70 % to 51,153.35 and Darden Restaurants reported worse-than-expected first-quarter financial results. - Crude oil prices rose 4.4 % to $96.25, while the U.S. current account deficit widened to $246 billion in the second quarter. - Major indices showed mixed results globally, with energy shares leading sector gains and materials stocks declining.
    APUS-21.46%SFIX+0.38%
  • Top Biotech Stocks To Keep An Eye On - September 24th

    Market Beat·Sep 24 at 04:02 PM
    GILD-1.87%NTRA+0.46%
  • Surrozen Gains Momentum as FDA Submission Opens Path for Lead Therapy

    benzinga_article·Sep 24 at 03:41 PM
    SRZN-2.27%
  • Surrozen soars 102% during regular trading to hit 52-week high

    US Stock Market Update·Sep 24 at 01:37 PM
    SRZN-2.27%
  • 12 Health Care Stocks Moving In Thursday's Pre-Market Session

    benzinga_article·Sep 24 at 12:05 PM
    SRZN-2.27%ARTL-3.92%
  • SRZN: Lead dual-mechanism therapy SZN-8141 enters trials, targeting major unmet needs in retinal disease

    Quartr·Sep 16 at 06:56 PM
    SRZN-2.27%
  • Surrozen submits FDA IND for SZN-8141 in diabetic macular edema

    PUBT·Sep 8 at 12:34 PM
    SRZN-2.27%